Z

Zai Lab (US) LLC

Develops, licenses, markets biopharmaceutical therapies

Vice President, Global Medical Affairs

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • A PhD and 16 years of progressive experience in medical affairs within the biopharmaceutical industry are required.
  • Clinical background in oncology or hematology; experience in precision oncology, antibody-drug conjugates, or immuno-oncology; and an existing key opinion leader network in small cell lung cancer, lung cancers, or neuroendocrine carcinomas are preferred.
  • Demonstrated track record of building and leading global or U.S. medical affairs organizations, including pre-launch, launch, and in-line medical support for oncology or specialty assets, and ability to partner cross-functionally with Commercial, Market Access, Regulatory, and Clinical Development are preferred.
  • Deep expertise in U.S. and global medical affairs operations, including medical science liaison programs, evidence generation, publication planning, medical education, advisory boards, and medical information, is preferred.
  • Proven pre-launch and launch medical affairs leadership, including health economics and outcomes research and market access medical strategy integration, is preferred; experience in a global U.S./China operating environment or cross-border clinical and regulatory programs is a plus.
  • An entrepreneurial mindset and demonstrated success building medical affairs organizations in high-growth, pre-commercial or early commercial U.S. biotech settings are preferred.
  • Strong scientific acumen and ability to translate complex clinical data into compelling medical narratives are preferred.
  • Excellent communication skills and executive presence, with comfort engaging key opinion leaders, health authorities, and C-suite stakeholders, are preferred.
  • Ability to work across several time zones and travel internationally is required.
  • Experience in cross-regional collaboration, including Asia/China, is preferred.
  • The highest standards of integrity and ethics are required.
  • An MD is preferred.

Responsibilities

  • Define and own the Medical Affairs strategy for the global oncology and immunology portfolio, providing leadership for global medical priorities, scientific engagement, and evidence generation, and partner with Medical Affairs leadership in China to coordinate and align global programs.
  • Provide executive-level scientific leadership and represent Medical Affairs across internal governance bodies, executive leadership forums, and cross-functional decision-making processes.
  • Ensure Medical Affairs activities comply with applicable regulations, industry standards, and internal policies; lead development and continuous improvement of Medical Affairs standard operating procedures and governance frameworks; oversee Medical Information operations and respond to escalated medical inquiries.
  • Develop and execute comprehensive pre-launch Medical Affairs plans for global pipeline assets in the U.S. and other regions outside China, establishing the scientific and clinical foundation ahead of commercial launch.
  • Partner with Regulatory Affairs on U.S. label development, lifecycle management, and health authority interactions, including Food and Drug Administration advisory committees and scientific advice meetings.
  • Lead key opinion leader identification, mapping, and engagement strategies across key oncology centers and academic institutions, and establish peer-level relationships with thought leaders in small cell lung cancer, neuroendocrine carcinomas, and other priority indications.
  • Partner with Commercial and Market Access teams to ensure scientific communication readiness, payer evidence packages, and health economics and outcomes research alignment as commercial infrastructure is built out.
  • Develop and oversee evidence generation plans across the U.S. and other regions outside China, including investigator-initiated studies, real-world evidence initiatives, and collaborative research studies with academic and community oncology centers.
  • Lead the publication strategy and oversight for global Medical Affairs programs, ensuring high-quality, timely dissemination of clinical data at key oncology congresses and in peer-reviewed journals.
  • Oversee development of scientific communication materials, medical education content, and advisory board programs that accurately reflect clinical data and support appropriate use.
  • Champion competitive intelligence and landscape analysis, translating insights into actionable medical strategy.
  • Engage key oncology cooperative groups, professional societies, and academic networks to advance disease education and support Zai Lab’s scientific reputation.
  • Own the patient advocacy strategy for the U.S. and other regions outside China; build relationships with relevant patient advocacy organizations, integrate patient perspectives into medical strategy, and support disease awareness and education initiatives.
  • Represent Zai Lab at national and international medical congresses, scientific symposia, and regulatory interactions as appropriate.
  • Work effectively across global time zones and travel up to 25%.
  • Build and lead a high-performing Medical Affairs team supporting the U.S. and other regions outside China; partner closely with Medical Affairs leadership in China on global programs and cross-regional coordination; recruit, develop, and retain scientific talent; establish clear accountability, performance metrics, and development plans; and foster a culture of scientific rigor, patient-centricity, and integrity.
  • Oversee departmental budget planning, resource allocation, and agency and vendor governance to ensure operational excellence.

Desired Qualifications

  • Experience in a global U.S./China operating environment or cross-border clinical and regulatory programs is a plus.

About the Company

Zai Lab (US) LLC

Develops, licenses, markets biopharmaceutical therapies

Zai Lab focuses on developing and commercializing therapies for cancer, infectious diseases, and autoimmune disorders, with a primary emphasis on China and the Asia-Pacific region. The company advances its products through R&D, clinical trials, and commercialization, and it manufactures small molecules and biologics in Suzhou to international quality standards. It distinguishes itself by collaborating with global partners to license and develop treatments, leveraging an integrated model that spans discovery, development, and market access in its target regions. Its goal is to bring effective, modern therapies to patients with unmet medical needs in its core markets, supported by product sales, licensing agreements, and strategic partnerships.

Company size
501-1,000
Company stage
IPO
Headquarters
Pudong, China
Founded
2014

Recently Posted Jobs

Explore more opportunities at Zai Lab (US) LLC

See more jobs